HISTOLOGICAL STUDIES ON THE OVARIES OF SOWS II. : ON THE BEHAVIOR OF ARGYROPHIL FIBERS IN THE VARIOUS STRUCTURES OF OVARIES

T. Yamashita

Abstract:

What problem does this paper attempt to address?

Estimates of pandemic excess mortality in India based on civil registration data

Murad Banaji,Aashish Gupta

DOI: https://doi.org/10.1371/journal.pgph.0000803

2022-12-09

Abstract:The population health impacts of the COVID-19 pandemic are less well understood in low and middle-income countries, where mortality surveillance before the pandemic was patchy. Interpreting the limited all-cause mortality data available in India is challenging. We use existing data on all-cause mortality from civil registration systems of twelve Indian states comprising around 60% of the national population to understand the scale and timing of excess deaths in India during the COVID-19 pandemic. We carefully characterize the reasons why registration is incomplete and estimate the extent of coverage in the data. Comparing the pandemic period to 2019, we estimate excess mortality in twelve Indian states, and extrapolate our estimates to the rest of India. We explore sensitivity of the estimates to various assumptions. For the 12 states with available all-cause mortality data, we document an increase of 28% in deaths during April 2020-May 2021 relative to expectations from 2019. This level of increase in mortality, if it applies nationally, would imply 2.8-2.9 million excess deaths. More limited data from June 2021 increases national estimates of excess deaths during April 2020-June 2021 to 3.8 million. With more optimistic or pessimistic assumptions, excess deaths during this period could credibly lie between 2.8 million and 5.2 million. The scale of estimated excess deaths is broadly consistent with expectations based on seroprevalence and COVID-19 fatality rates observed internationally. Moreover, the timing of excess deaths and recorded COVID-19 deaths is similar-they rise and fall at the same time. The surveillance of pandemic mortality in India has been extremely poor, with 8-10 times as many excess deaths as officially recorded COVID-19 deaths. India is among the countries most severely impacted by the pandemic. Our approach highlights the utility of all-cause mortality data, as well as the significant challenges in interpreting it.
The Mortality Burden from COVID in Low-Income Settings: Evidence from Verbal Autopsies in India

Anup Malani,Wanran Zhao

DOI: https://doi.org/10.1101/2024.01.02.24300728

2024-01-03

Abstract:Measuring the mortality burden of SARS-CoV-2 in lower-income countries is difficult because death registries are incomplete and lack cause of death. We address this problem in India, which had the second-highest number of officially reported cases. We completed WHO-compliant verbal autopsy (VA) surveys on roughly 20,000 deaths drawn from a population-representative sample. SARS-CoV-2 deaths spike in June 2020, just after India’s lockdown, and in May 2021, after its second wave. During those spikes the virus is responsible for 23.3% and 35.8% of all deaths, respectively. Cardiovascular deaths also spike during the start of the pandemic. We find that the death rate rises by 81% during the pandemic, SARS-CoV-2 is responsible for 33% of these excess deaths, and cardiovascular disease for 23% of these deaths.

Public and Global Health
Large and unequal life expectancy declines during the COVID-19 pandemic in India in 2020

Aashish Gupta,Payal Hathi,Murad Banaji,Prankur Gupta,Ridhi Kashyap,Vipul Paikra,Kanika Sharma,Anmol Somanchi,Nikkil Sudharsanan,Sangita Vyas

DOI: https://doi.org/10.1126/sciadv.adk2070

IF: 13.6

2024-07-20

Science Advances

Abstract:Global population health during the COVID-19 pandemic is poorly understood because of weak mortality monitoring in low- and middle-income countries. High-quality survey data on 765,180 individuals, representative of one-fourth of India's population, uncover patterns missed by incomplete vital statistics and disease surveillance. Compared to 2019, life expectancy at birth was 2.6 years lower and mortality was 17% higher in 2020, implying 1.19 million excess deaths in 2020. Life expectancy declines in India were larger and had a younger age profile than in high-income countries. Increases in mortality were greater than expected based on observed seroprevalence and international infection fatality rates, most prominently among the youngest and older age groups. In contrast to global patterns, females in India experienced a life expectancy decline that was 1 year larger than losses for males. Marginalized social groups experienced greater declines than the most privileged social group. These findings uncover large and unequal mortality impacts during the pandemic in the world's most populous country.

multidisciplinary sciences
Time-of-flight mass spectrometric analysis of ion formation in hypervelocity impact of organic polymer microspheres: comparison with secondary ion mass spectrometry, (252)Cf mass spectrometry and laser mass spectrometry.

J. Kissel,F. R. Krueger

DOI: https://doi.org/10.1002/RCM.431

IF: 2.586

2001-09-30

Rapid Communications in Mass Spectrometry

Abstract:Unisized 1.6-microm polystyrene microspheres coated with PEDOT (polyethylene-dioxythiophene) were accelerated to speeds of 6-16 km/s and shot onto a silver target. Either positive or negative ions, both instantaneously formed by the impact process, have been analyzed by time-of-flight mass spectrometry (TOF). Apparently, the processes that control the formation of ions of either polarity depend on the impact velocity. Comparing the results with those of secondary ion mass spectrometry with primary ion energy in both the elastic and the inelastic ((252)Cf-MS) energy loss regimes, some reaction mechanisms of the polymer ions for different energy densities could be elucidated. Some aspects of ion formation are also related to those found in pulsed laser ion generation from these microspheres. This investigation was performed in order to further improve the method of analyzing the organic fraction of interstellar, interplanetary, and cometary dust particles impinging on the targets of the "CIDA" time-of-flight (TOF) mass spectrometers on-board the NASA comet missions "STARDUST" and "CONTOUR".
Mortality trends during the first three waves of the COVID-19 pandemic at an urban district hospital in South Africa: A retrospective comparative analysis

O Hirachund,C Pennefather,M Naidoo

DOI: https://doi.org/10.7196/samj.2024.v114i2.1054

2024-03-09

South African Medical Journal

Abstract:Background. Severe acute respiratory syndrome coronavirus 2 (SARS‐COV‐2) is the virus responsible for the COVID‐19 (C19) pandemic. South Africa (SA) experienced multiple periods of increased transmission. Tertiary, regional and central hospitals were overwhelmed, resulting in low acceptance rates. Objectives. To compare mortality trends of patients who died in hospital from SARS‐CoV‐2 infection during the first three waves of infection as defined by the National Institute of Communicable Diseases of South Africa. Methods. This was a retrospective cohort study at a district level hospital of 311 adults who died within the first three waves of COVID‐19. The study analysed case and crude fatality rates, baseline characteristics, symptomatology, clinical presentation and management of patients. Results. Waves 1, 2 and 3 yielded case fatality rates of 14.5%, 27.6% and 6.3%, respectively, and crude fatality rates of 16.7%, 33.0% and 12.2%, respectively. Black Africans were less likely to die during the third wave (odds ratio (OR) 0.54; 95% confidence interval (CI) 0.31 ‐ 0.94). Patients in the second wave had clinical frailty scores of <5 (OR 2.51; 95% CI 1.56 ‐ 4.03). Obesity was most prevalent in the second wave (OR 1.87; 95% CI 1.01 ‐ 3.46), and dyslipidaemia (OR 3.03; 95% CI 1.59 ‐ 5.77) and ischaemic heart disease (OR 3.77; 95% CI .71 ‐ 8.33) were most prevalent during the third wave. Severe ground glass appearance was most common during the second wave (OR 2.37; 95% CI 1.49 ‐ 3.77). Renal impairment was most prevalent during the first wave (OR 3.28; 95% CI 1.59 ‐ 6.77), and thrombo‐ embolic phenomena were less common during wave three (OR 0.12; 95% CI 0.02 ‐ 0.91). Conclusion. The Beta variant was the most virulent, with the highest case and crude fatality rates in wave 2.

medicine, general & internal
Conventional and frugal methods of estimating COVID-19-related excess deaths and undercount factors

Abhishek M. Dedhe,Aakash A. Chowkase,Niramay V. Gogate,Manas M. Kshirsagar,Rohan Naphade,Atharv Naphade,Pranav Kulkarni,Mrunmayi Naik,Aarya Dharm,Soham Raste,Shravan Patankar,Chinmay M. Jogdeo,Aalok Sathe,Soham Kulkarni,Vibha Bapat,Rohinee Joshi,Kshitij Deshmukh,Subhash Lele,Kody J. Manke-Miller,Jessica F. Cantlon,Pranav S. Pandit

DOI: https://doi.org/10.1038/s41598-024-57634-6

IF: 4.6

2024-05-08

Scientific Reports

Abstract:Across the world, the officially reported number of COVID-19 deaths is likely an undercount. Establishing true mortality is key to improving data transparency and strengthening public health systems to tackle future disease outbreaks. In this study, we estimated excess deaths during the COVID-19 pandemic in the Pune region of India. Excess deaths are defined as the number of additional deaths relative to those expected from pre-COVID-19-pandemic trends. We integrated data from: (a) epidemiological modeling using pre-pandemic all-cause mortality data, (b) discrepancies between media-reported death compensation claims and official reported mortality, and (c) the "wisdom of crowds" public surveying. Our results point to an estimated 14,770 excess deaths [95% CI 9820–22,790] in Pune from March 2020 to December 2021, of which 9093 were officially counted as COVID-19 deaths. We further calculated the undercount factor—the ratio of excess deaths to officially reported COVID-19 deaths. Our results point to an estimated undercount factor of 1.6 [95% CI 1.1–2.5]. Besides providing similar conclusions about excess deaths estimates across different methods, our study demonstrates the utility of frugal methods such as the analysis of death compensation claims and the wisdom of crowds in estimating excess mortality.

multidisciplinary sciences
Magnitude, demographics and dynamics of the effect of the first wave of the COVID-19 pandemic on all-cause mortality in 21 industrialized countries

Vasilis Kontis,James E. Bennett,Theo Rashid,Robbie M. Parks,Jonathan Pearson-Stuttard,Michel Guillot,Perviz Asaria,Bin Zhou,Marco Battaglini,Gianni Corsetti,Martin McKee,Mariachiara Di Cesare,Colin D. Mathers,Majid Ezzati

DOI: https://doi.org/10.1038/s41591-020-1112-0

IF: 82.9

2020-10-14

Nature Medicine

Abstract:The Coronavirus Disease 2019 (COVID-19) pandemic has changed many social, economic, environmental and healthcare determinants of health. We applied an ensemble of 16 Bayesian models to vital statistics data to estimate the all-cause mortality effect of the pandemic for 21 industrialized countries. From mid-February through May 2020, 206,000 (95% credible interval, 178,100–231,000) more people died in these countries than would have had the pandemic not occurred. The number of excess deaths, excess deaths per 100,000 people and relative increase in deaths were similar between men and women in most countries. England and Wales and Spain experienced the largest effect: ~100 excess deaths per 100,000 people, equivalent to a 37% (30–44%) relative increase in England and Wales and 38% (31–45%) in Spain. Bulgaria, New Zealand, Slovakia, Australia, Czechia, Hungary, Poland, Norway, Denmark and Finland experienced mortality changes that ranged from possible small declines to increases of 5% or less in either sex. The heterogeneous mortality effects of the COVID-19 pandemic reflect differences in how well countries have managed the pandemic and the resilience and preparedness of the health and social care system.

biochemistry & molecular biology,cell biology,medicine, research & experimental
The WHO estimates of excess mortality associated with the COVID-19 pandemic

William Msemburi,Ariel Karlinsky,Victoria Knutson,Serge Aleshin-Guendel,Somnath Chatterji,Jon Wakefield

DOI: https://doi.org/10.1038/s41586-022-05522-2

IF: 64.8

2022-12-16

Nature

Abstract:The World Health Organization has a mandate to compile and disseminate statistics on mortality, and we have been tracking the progression of the COVID-19 pandemic since the beginning of 2020 1 . Reported statistics on COVID-19 mortality are problematic for many countries owing to variations in testing access, differential diagnostic capacity and inconsistent certification of COVID-19 as cause of death. Beyond what is directly attributable to it, the pandemic has caused extensive collateral damage that has led to losses of lives and livelihoods. Here we report a comprehensive and consistent measurement of the impact of the COVID-19 pandemic by estimating excess deaths, by month, for 2020 and 2021. We predict the pandemic period all-cause deaths in locations lacking complete reported data using an overdispersed Poisson count framework that applies Bayesian inference techniques to quantify uncertainty. We estimate 14.83 million excess deaths globally, 2.74 times more deaths than the 5.42 million reported as due to COVID-19 for the period. There are wide variations in the excess death estimates across the six World Health Organization regions. We describe the data and methods used to generate these estimates and highlight the need for better reporting where gaps persist. We discuss various summary measures, and the hazards of ranking countries' epidemic responses.

multidisciplinary sciences
Age-specific mortality and immunity patterns of SARS-CoV-2

Megan O’Driscoll,Gabriel Ribeiro Dos Santos,Lin Wang,Derek A. T. Cummings,Andrew S. Azman,Juliette Paireau,Arnaud Fontanet,Simon Cauchemez,Henrik Salje

DOI: https://doi.org/10.1038/s41586-020-2918-0

IF: 64.8

2020-11-02

Nature

Abstract:Estimating the size and infection severity of the SARS-CoV-2 epidemic is made challenging by inconsistencies in available data. The number of COVID-19 deaths is often used as a key indicator for the epidemic size, but observed deaths represent only a minority of all infections<sup>1,2</sup>. Additionally, the heterogeneous burden in nursing homes and variable reporting of deaths in elderly individuals can hamper direct comparisons across countries of the underlying level of transmission and mortality rates<sup>3</sup>. Here we use age-specific COVID-19 death data from 45 countries and the results of 22 seroprevalence studies to investigate the consistency of infection and fatality patterns across multiple countries. We find that the age distribution of deaths in younger age groups (<65 years) is very consistent across different settings and demonstrate how this data can provide robust estimates of the share of the population that has been infected. We estimate that the infection-to-fatality ratio (IFR) is lowest among 5-9 years old, with a log-linear increase by age among individuals older than 30 years. Population age-structures and heterogeneous burdens in nursing homes explain some but not all of the heterogeneity between countries in infection-fatality ratios. Among the 45 countries included in our analysis, we estimate approximately 5% of these populations had been infected by the 1st of September 2020, with much higher transmission likely to have occurred in a number of Latin American countries. This simple modelling framework can help countries assess the progression of the pandemic and can be applied wherever reliable age-specific death data exists.

multidisciplinary sciences
Comorbidities and their association with COVID-19 mortality in Mexico between January 2020 and August 2021

Ryan J. Lowhorn,Mohammed Chowdhury,Symon Kimitei,Sammie Haskin,Mohammad Masum,A. K. M. Fazlur Rahman

DOI: https://doi.org/10.1371/journal.pone.0296895

IF: 3.7

2024-04-17

PLoS ONE

Abstract:By August 17, 2021, 4.3 million people had died globally as a result of SARS-CoV-2 infection. While data collection is ongoing, it is abundantly obvious that this is one of the most significant public health crises in modern history. Consequently, global efforts are being made to attain a greater understanding of this disease and to identify risk factors associated with more severe outcomes. The goal of this study is to identify clinical characteristics and risk factors associated with COVID-19 mortality in Mexico. The dataset used in this study was released by Sistema Nacional de Vigilancia Epidemiologica de Enfermedades Respiratorias (SISVER) de la Secretaría de Salud and contains 2.9 million COVID-19 cases. The effects of risk factors on COVID-19 mortality were estimated using multivariable logistic regression models with generalized estimation equation and Kaplan-Meier curves. Case fatality rates, case hospitalization rates are also reported using the Centers for Disease Control and Prevention (CDC) USA death-to-case ratio method. In general, older males with pre-existing conditions had higher odds of death. Age greater than 40, male sex, hypertension, diabetes, and obesity are associated with higher COVID-19 mortality. End-stage renal disease, chronic obstructive pulmonary disease, and immunosuppression are all linked with COVID-19 patient fatalities. Smoking and Asthma are associated with lower COVID-19 mortality which is consistent with findings from the article published in Nature based on National Health Service (NHS) of UK dataset (17 million cases). Intensive care unit (ICU), patient intubation, and pneumonia diagnosis are shown to substantially increase mortality risk for COVID-19 patients.

multidisciplinary sciences
Are numbers deceptive? Is death auditing a solution for death analysis, among the COVID-19 deceased?: A study from a dedicated COVID-19 hospital in Faridabad, Haryana

Pooja Goyal,Ruchi Arora Sachdeva,Lokesh Parashar,Asit Kumar Sikary,Aamir Tarique

DOI: https://doi.org/10.4103/jfmpc.jfmpc_2063_20

Abstract:Background: COVID-19 pandemic has havocked the entire world and India has not been spared. The focus is not only on the containment but on the reduction in mortality also. The objective of the study was to know the trend of COVID-19 deaths in a 510-bedded dedicated COVID-19 hospital and to determine the cause of death and various factors associated with these deaths. Method: A descriptive study was conducted in a COVID-dedicated hospital setting to analyze deaths occurring during April--July, 2020 using a standard death audit proforma. Results: A total number of 95 COVID-19 patients died in ICU. The mortality rate among ICU patients varied from 24.6% to 52.9%. Most of the cases were referred from other hospitals. About 64% of the deceased was admitted in severe condition and 34% of cases were referred on ventilator support. The week-wise trend revealed a positive association between the number of deaths and the number of referred cases as well as the number of patients received on ventilator support and in severe condition. About one-third of cases were late in seeking treatment at health centers with the same weekly trend. Being unaware of the condition (1%) and the stigma associated with the disease (32%) were the reasons behind it. Common direct causes of death were pneumonia (73%), pneumonia complicated with sepsis (16%), and acute respiratory disease syndrome (ARDS) (7%). Conclusion: High case fatality rate in the ICU of a referral COVID-dedicated hospital is mainly because of the admission of patients in severe conditions.
Disability-adjusted life years (DALYs) due to the direct health impact of COVID-19 in India, 2020

Balbir B. Singh,Brecht Devleesschauwer,Mehar S. Khatkar,Mark Lowerison,Baljit Singh,Navneet K. Dhand,Herman W. Barkema

DOI: https://doi.org/10.1038/s41598-022-06505-z

IF: 4.6

2022-02-14

Scientific Reports

Abstract:Abstract COVID-19 has affected all countries. Its containment represents a unique challenge for India due to a large population (> 1.38 billion) across a wide range of population densities. Assessment of the COVID-19 disease burden is required to put the disease impact into context and support future pandemic policy development. Here, we present the national-level burden of COVID-19 in India in 2020 that accounts for differences across urban and rural regions and across age groups. Input data were collected from official records or published literature. The proportion of excess COVID-19 deaths was estimated using the Institute for Health Metrics and Evaluation, Washington data. Disability-adjusted life years (DALY) due to COVID-19 were estimated in the Indian population in 2020, comprised of years of life lost (YLL) and years lived with disability (YLD). YLL was estimated by multiplying the number of deaths due to COVID-19 by the residual standard life expectancy at the age of death due to the disease. YLD was calculated as a product of the number of incident cases of COVID-19, disease duration and disability weight. Scenario analyses were conducted to account for excess deaths not recorded in the official data and for reported COVID-19 deaths. The direct impact of COVID-19 in 2020 in India was responsible for 14,100,422 (95% uncertainty interval [UI] 14,030,129–14,213,231) DALYs, consisting of 99.2% (95% UI 98.47–99.64%) YLLs and 0.80% (95% UI 0.36–1.53) YLDs. DALYs were higher in urban (56%; 95% UI 56–57%) than rural areas (44%; 95% UI 43.4–43.6) and in men (64%) than women (36%). In absolute terms, the highest DALYs occurred in the 51–60-year-old age group (28%) but the highest DALYs per 100,000 persons were estimated for the 71–80 years old age group (5481; 95% UI 5464–5500 years). There were 4,815,908 (95% UI 4,760,908–4,924,307) DALYs after considering reported COVID-19 deaths only. The DALY estimations have direct and immediate implications not only for public policy in India, but also internationally given that India represents one sixth of the world’s population.

multidisciplinary sciences
A Practical Performance Analysis of CRS-Aided Channel Estimation Algorithms for LTE Downlink System

Yannan Yuan,Lianfeng Huang,Ruogui Xiao,Xin Qi,Min Huang

DOI: https://doi.org/10.1007/978-3-642-30493-4_30

2011-10-19

Abstract:
Global Excess Mortality During COVID-19 Pandemic: A Systematic Review and Meta-Analysis

Weijing Shang,Yaping Wang,Jie Yuan,Zirui Guo,Jue Liu,Min Liu

DOI: https://doi.org/10.3390/vaccines10101702

2022-01-01

Vaccines

Abstract:Background: Currently, reported COVID-19 deaths are inadequate to assess the impact of the pandemic on global excess mortality. All-cause excess mortality is a WHO-recommended index for assessing the death burden of COVID-19. However, the global excess mortality assessed by this index remains unclear. We aimed to assess the global excess mortality during the COVID-19 pandemic. Methods: We searched PubMed, EMBASE, and Web of Science for studies published in English between 1 January 2020, and 21 May 2022. Cross-sectional and cohort studies that reported data about excess mortality during the pandemic were included. Two researchers independently searched the published studies, extracted data, and assessed quality. The Mantel–Haenszel random-effects method was adopted to estimate pooled risk difference (RD) and their 95% confidence intervals (CIs). Results: A total of 79 countries from twenty studies were included. During the COVID-19 pandemic, of 2,228,109,318 individuals, 17,974,051 all-cause deaths were reported, and 15,498,145 deaths were expected. The pooled global excess mortality was 104.84 (95% CI 85.56–124.13) per 100,000. South America had the highest pooled excess mortality [134.02 (95% CI: 68.24–199.80) per 100,000], while Oceania had the lowest [−32.15 (95% CI: −60.53–−3.77) per 100,000]. Developing countries had higher excess mortality [135.80 (95% CI: 107.83–163.76) per 100,000] than developed countries [68.08 (95% CI: 42.61–93.55) per 100,000]. Lower middle-income countries [133.45 (95% CI: 75.10–191.81) per 100,000] and upper-middle-income countries [149.88 (110.35–189.38) per 100,000] had higher excess mortality than high-income countries [75.54 (95% CI: 53.44–97.64) per 100,000]. Males had higher excess mortality [130.10 (95% CI: 94.15–166.05) per 100,000] than females [102.16 (95% CI: 85.76–118.56) per 100,000]. The population aged ≥ 60 years had the highest excess mortality [781.74 (95% CI: 626.24–937.24) per 100,000]. Conclusions: The pooled global excess mortality was 104.84 deaths per 100,000, and the number of reported all-cause deaths was higher than expected deaths during the global COVID-19 pandemic. In South America, developing and middle-income countries, male populations, and individuals aged ≥ 60 years had a heavier excess mortality burden.
Estimating Global and Country-Specific Excess Mortality During the COVID-19 Pandemic

Victoria Knutson,Serge Aleshin-Guendel,Ariel Karlinsky,William Msemburi,Jon Wakefield

DOI: https://doi.org/10.48550/arXiv.2205.09081

2022-05-19

Abstract:Estimating the true mortality burden of COVID-19 for every country in the world is a difficult, but crucial, public health endeavor. Attributing deaths, direct or indirect, to COVID-19 is problematic. A more attainable target is the "excess deaths", the number of deaths in a particular period, relative to that expected during "normal times", and we estimate this for all countries on a monthly time scale for 2020 and 2021. The excess mortality requires two numbers, the total deaths and the expected deaths, but the former is unavailable for many countries, and so modeling is required for these countries. The expected deaths are based on historic data and we develop a model for producing expected estimates for all countries and we allow for uncertainty in the modeled expected numbers when calculating the excess. We describe the methods that were developed to produce the World Health Organization (WHO) excess death estimates. To achieve both interpretability and transparency we developed a relatively simple overdispersed Poisson count framework, within which the various data types can be modeled. We use data from countries with national monthly data to build a predictive log-linear regression model with time-varying coefficients for countries without data. For a number of countries, subnational data only are available, and we construct a multinomial model for such data, based on the assumption that the fractions of deaths in sub-regions remain approximately constant over time. Based on our modeling, the point estimate for global excess mortality, over 2020-2021, is 14.9 million, with a 95% credible interval of (13.3, 16.6) million. This leads to a point estimate of the ratio of excess deaths to reported COVID-19 deaths of 2.75, which is a huge discrepancy.

Applications,Methodology
An Analysis of COVID-19 Mortality During the Dominancy of Alpha, Delta, and Omicron in the USA

Mohammad Tabatabai,Paul D. Juarez,Patricia Matthews-Juarez,Derek M. Wilus,Aramandla Ramesh,Donald J. Alcendor,Niki Tabatabai,Karan P. Singh

DOI: https://doi.org/10.1177/21501319231170164

2023-04-23

Journal of Primary Care & Community Health

Abstract:Journal of Primary Care &Community Health, Volume 14, Issue , January-December 2023. Background:The objective of the study was to measure the risk of death due to COVID-19 in relation to individuals' characteristics, and severity of their disease during the dominant periods of Alpha, Delta, and Omicron variants have influenced mortality rates.Methods:This study was conducted using COVID-19 Centers for Disease Control and Prevention (CDC) Case Surveillance Public Data Taskforce for 57 states, and United States territories between January 1, 2020 and March 20, 2022. Multivariable binary Hyperbolastic regression of type I was used to analyzes the data.Results:Seniors and ICU-admitted patients had the highest risk of death. For each additional percent increase in fully vaccinated individuals, the odds of death deceased by 1%. The odds of death prior to vaccine availability, compared to post vaccine availability, was 1.27. When comparing the time periods each variant was dominant, the odds of death was 3.45-fold higher during Delta compared to Alpha. All predictor variables had P-values ≤.001.Conclusion:There was a noticeable difference in the odds of death among subcategories of age, race/ethnicity, sex, PMCs, hospitalization, ICU, vaccine availability, variant, and percent of fully vaccinated individuals.
Risk Factors associated with COVID-19 Patients in India: A Single Center Retrospective Cohort Study

Darshana Rathod,Ketan Kargirwar,Mayur Patel,Vivek Kumar,Kavita Shalia,Pratibha Singhal

DOI: https://doi.org/10.5005/japi-11001-0263

Abstract:Background and objectives: The coronavirus disease 2019 (COVID-19) outbreak has caused a worldwide pandemic, resulting in >3.8 million deaths. Our aim is to identify the risk factors associated with in-hospital mortality using survival analysis considering the characteristics and outcomes of COVID-19 patients admitted to a dedicated tertiary-care hospital in Mumbai, India. Materials and methods: In a retrospective cohort study, 565 patients admitted from 28th March 2020 to 30th June 2020 were enrolled, and a follow-up was conducted till August 2020. To investigate the impact of COVID-19, survival analysis was performed using the Kaplan-Meier method. Potential risk factors associated with mortality were analyzed using logistic regression models for multivariate analysis and the Cox proportional hazards model for estimating hazard ratios (HRs). Results: From the 565 positive COVID-19 cases, 49 patients died (8.7%) and 516 (91.3%) were discharged. Overall, 119 patients (20%) required intensive care unit (ICU) admission, of which 70 (58%) patients survived. The Kaplan-Meier survival curve showed a significant association of COVID-19 infection with age (≥60; p = 0.008), hypertension (p = 0.03), dialysis (p = 0.0001), lung commodities (p = 0.01), breathlessness (p = 0.0001), severe disease upon high-resolution computed tomography (HRCT) analysis (p = 0.0001), ICU admission (p = 0.0001), and low lymphocyte count at admission (p = 0.0001). Additionally, patients receiving tocilizumab (p = 0.0001) and deprived of hydroxychloroquine (HCQ) + azithromycin (azee) (p = 0.0001) were estimated at a high risk of mortality. Interpretation and conclusion: Coronavirus disease 2019 (COVID-19) increased the risk of mortality in patients with increased age, comorbidities, and severe symptoms upon treatment with an immunosuppressant (tocilizumab). However, patients treated with HCQ + azee showed favorable results due to their antiviral effects in vitro.
Temporal Trend in Mortality from COVID-19 Associated with Cardiovascular Disease

Sarau,A. V.,Luo,S.,Chen,E. Y.-S.,Gawel,S.,Desai,P.,Tippireddy,N.,Saldanha,A.,Suboc,T. M.,Cloherty,G.,Landay,A. L.,Volgman,A. S.

DOI: https://doi.org/10.1101/2023.04.26.23289183

2023-05-02

MedRxiv

Abstract:Background: The COVID-19 pandemic has endured for over three years with over twelve variants afflicting humans worldwide. The impact and longevity of the pandemic has driven the medical community and researchers to identify high-risk populations, yet few studies have explored temporal trends during the pandemic. The objective of this study is to investigate trends in all-cause mortality associated with co-morbid cardiovascular disease (CVD) throughout the consecutive waves of the COVID-19 pandemic. Methods: A retrospective cohort study was conducted on patients with COVID-19 infection who received care at a tertiary care center in Chicago between March 2020 and September 2022. Multivariable logistic regression was used to investigate associations between co-existing CVD (defined as congestive heart failure, myocardial infarction, cerebrovascular disease, peripheral vascular disease) and mortality, adjusting for age, sex, race, and comorbidities defined in the Charlson comorbidity index. Results: The study included 38651 participants (mean age 45 years, 57.6% female, 11.4% with co-existing CVD). All-cause mortality in COVID-19 patients was highest during the Delta wave and remained elevated until the late Omicron wave. Mortality associated with co-existing CVD increased during the early pandemic waves, decreased in the later waves, but remained elevated relative to the overall population. When adjusted for age, sex, and race, all-cause mortality was 2.3-fold higher in patients with co-existing CVD compared to those with non-CVD comorbidities (OR = 2.30, 95% CI 1.95 - 2.62; p < 0.001). Conclusions: While overall mortality rates declined toward the later waves of the pandemic, all-cause mortality associated with CVD remained elevated compared to individuals without CVD.
Preliminary Estimates of Years of Life Lost (YLL) Due to COVID-19 in India

Abhaya Indrayan,Aman Mishra,Mona Pathak

DOI: https://doi.org/10.1101/2020.10.24.20218693

2020-10-27

Abstract:Abstract Objectives More than 7 million cases of COVID have been detected in India by the middle of October 2020 and more than 100 thousand deaths have occurred. In this communication, we present an estimate of the years of life lost (YLL) due to COVID-19 so far and the projection for the full year so that the health damage by this new disease can be compared with some other ailments. Design Records based study Method The YLL by one premature death is the expectation of life at that age. To calculate YLL, the age-wise distribution of COVID cases and deaths was obtained from the official sources of the government of India. Similar calculations were done for the general population from all causes for comparison. Results A total of more than 2 million years of life have already lost due to COVID-19 and the pattern indicates that we may end up with nearly 4 million YLL due to this disease in India. This is nearly 20 years lost per COVID death, 303 years lost per 1000 cases of COVID, and about 3 years lost per 1000 population in a full year. The age-group 50–59 years has been particularly affected. Other important findings are summarized as key messages. Conclusion The years of life lost so far and anticipated in full-year are enormous but may still be lower compared with some other causes such as road injuries.
The mortality burden related to COVID-19 in 2020 and 2021 - years of life lost and excess mortality in 13 countries and sub-national regions in Southern and Eastern Europe, and Central Asia

Caoimhe Cawley,Mehtap Çakmak Barsbay,Tolkun Djamangulova,Batmanduul Erdenebat,Šeila Cilović-Lagarija,Vladyslav Fedorchenko,Jonila Gabrani,Natalya Glushkova,Arijana Kalaveshi,Levan Kandelaki,Konstantine Kazanjan,Khorolsuren Lkhagvasuren,Milena Santric Milicevic,Diloram Sadikkhodjayeva,Siniša Skočibušić,Stela Stojisavljevic,Gülcan Tecirli,Natasa Terzic,Alexander Rommel,Annelene Wengler,for the BoCO-19-Study Group

DOI: https://doi.org/10.3389/fpubh.2024.1378229

IF: 5.2

2024-06-07

Frontiers in Public Health

Abstract:Introduction: Between 2021 and 2023, a project was funded in order to explore the mortality burden (YLL–Years of Life Lost, excess mortality) of COVID-19 in Southern and Eastern Europe, and Central Asia. Methods: For each national or sub-national region, data on COVID-19 deaths and population data were collected for the period March 2020 to December 2021. Unstandardized and age-standardised YLL rates were calculated according to standard burden of disease methodology. In addition, all-cause mortality data for the period 2015–2019 were collected and used as a baseline to estimate excess mortality in each national or sub-national region in the years 2020 and 2021. Results: On average, 15–30 years of life were lost per death in the various countries and regions. Generally, YLL rates per 100,000 were higher in countries and regions in Southern and Eastern Europe compared to Central Asia. However, there were differences in how countries and regions defined and counted COVID-19 deaths. In most countries and sub-national regions, YLL rates per 100,000 (both age-standardised and unstandardized) were higher in 2021 compared to 2020, and higher amongst men compared to women. Some countries showed high excess mortality rates, suggesting under-diagnosis or under-reporting of COVID-19 deaths, and/or relatively large numbers of deaths due to indirect effects of the pandemic. Conclusion: Our results suggest that the COVID-19 mortality burden was greater in many countries and regions in Southern and Eastern Europe compared to Central Asia. However, heterogeneity in the data (differences in the definitions and counting of COVID-19 deaths) may have influenced our results. Understanding possible reasons for the differences was difficult, as many factors are likely to play a role (e.g., differences in the extent of public health and social measures to control the spread of COVID-19, differences in testing strategies and/or vaccination rates). Future cross-country analyses should try to develop structured approaches in an attempt to understand the relative importance of such factors. Furthermore, in order to improve the robustness and comparability of burden of disease indicators, efforts should be made to harmonise case definitions and reporting for COVID-19 deaths across countries.

public, environmental & occupational health

HISTOLOGICAL STUDIES ON THE OVARIES OF SOWS II. : ON THE BEHAVIOR OF ARGYROPHIL FIBERS IN THE VARIOUS STRUCTURES OF OVARIES

Estimates of pandemic excess mortality in India based on civil registration data

The Mortality Burden from COVID in Low-Income Settings: Evidence from Verbal Autopsies in India

Large and unequal life expectancy declines during the COVID-19 pandemic in India in 2020

Time-of-flight mass spectrometric analysis of ion formation in hypervelocity impact of organic polymer microspheres: comparison with secondary ion mass spectrometry, (252)Cf mass spectrometry and laser mass spectrometry.

Mortality trends during the first three waves of the COVID-19 pandemic at an urban district hospital in South Africa: A retrospective comparative analysis

Conventional and frugal methods of estimating COVID-19-related excess deaths and undercount factors

Magnitude, demographics and dynamics of the effect of the first wave of the COVID-19 pandemic on all-cause mortality in 21 industrialized countries

The WHO estimates of excess mortality associated with the COVID-19 pandemic

Age-specific mortality and immunity patterns of SARS-CoV-2

Comorbidities and their association with COVID-19 mortality in Mexico between January 2020 and August 2021

Are numbers deceptive? Is death auditing a solution for death analysis, among the COVID-19 deceased?: A study from a dedicated COVID-19 hospital in Faridabad, Haryana

Disability-adjusted life years (DALYs) due to the direct health impact of COVID-19 in India, 2020

A Practical Performance Analysis of CRS-Aided Channel Estimation Algorithms for LTE Downlink System

Global Excess Mortality During COVID-19 Pandemic: A Systematic Review and Meta-Analysis

Estimating Global and Country-Specific Excess Mortality During the COVID-19 Pandemic

An Analysis of COVID-19 Mortality During the Dominancy of Alpha, Delta, and Omicron in the USA

Risk Factors associated with COVID-19 Patients in India: A Single Center Retrospective Cohort Study

Temporal Trend in Mortality from COVID-19 Associated with Cardiovascular Disease

Preliminary Estimates of Years of Life Lost (YLL) Due to COVID-19 in India

The mortality burden related to COVID-19 in 2020 and 2021 - years of life lost and excess mortality in 13 countries and sub-national regions in Southern and Eastern Europe, and Central Asia